Daniel Yeo

678 total citations
11 papers, 408 citations indexed

About

Daniel Yeo is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daniel Yeo has authored 11 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Daniel Yeo's work include Heart Failure Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Advanced Breast Cancer Therapies (2 papers). Daniel Yeo is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Advanced Breast Cancer Therapies (2 papers). Daniel Yeo collaborates with scholars based in Singapore, Netherlands and New Zealand. Daniel Yeo's co-authors include Carolyn S.P. Lam, Fazlur Jaufeerally, David Sim, Hean Yee Ong, Lieng Hsi Ling, Mark Richards, Tze Pin Ng, Kui Toh Gerard Leong, Siew Pang Chan and Fatih Arslan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Daniel Yeo

11 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Yeo Singapore 8 328 169 51 47 42 11 408
Hiroshi Yamagami Japan 9 182 0.6× 168 1.0× 37 0.7× 106 2.3× 56 1.3× 31 363
In Hyun Jung South Korea 11 257 0.8× 80 0.5× 134 2.6× 40 0.9× 85 2.0× 35 372
Takatomo Nakajima Japan 7 278 0.8× 78 0.5× 106 2.1× 35 0.7× 97 2.3× 20 402
Csaba Csobay-Novák Hungary 11 139 0.4× 201 1.2× 88 1.7× 66 1.4× 82 2.0× 62 378
Alberto Pivetta Italy 13 592 1.8× 68 0.4× 154 3.0× 35 0.7× 59 1.4× 14 673
J Candell Spain 7 171 0.5× 114 0.7× 107 2.1× 66 1.4× 19 0.5× 16 325
Şule Karakelleoğlu Türkiye 11 302 0.9× 37 0.2× 50 1.0× 80 1.7× 123 2.9× 36 374
Cansın Tulunay Kaya Türkiye 11 180 0.5× 96 0.6× 63 1.2× 73 1.6× 40 1.0× 36 335
Clotilde Roy Belgium 11 440 1.3× 110 0.7× 69 1.4× 50 1.1× 210 5.0× 18 531
Cihan Altın Türkiye 12 285 0.9× 108 0.6× 127 2.5× 42 0.9× 72 1.7× 38 383

Countries citing papers authored by Daniel Yeo

Since Specialization
Citations

This map shows the geographic impact of Daniel Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Yeo more than expected).

Fields of papers citing papers by Daniel Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Yeo. The network helps show where Daniel Yeo may publish in the future.

Co-authorship network of co-authors of Daniel Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Yeo. A scholar is included among the top collaborators of Daniel Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Yeo. Daniel Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Yeo, Daniel, et al.. (2021). Real-world outcomes from the systemic use of CDK 4/6 inhibitors (CDKIs) in the management of ER positive (+) HER2 negative (-) metastatic breast cancer (mBC).. Journal of Clinical Oncology. 39(15_suppl). e13031–e13031. 2 indexed citations
3.
Chin, Calvin, Thu Thao Le, Gurpreet K. Singh, et al.. (2021). Echocardiographic global longitudinal strain as a marker of myocardial fibrosis predicts outcomes in aortic stenosis. European Heart Journal. 42(Supplement_1). 2 indexed citations
4.
Tan, Eugene S.J., Siew‐Pang Chan, Jenny Chong, et al.. (2020). Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure. Clinical Chemistry. 67(1). 216–226. 18 indexed citations
5.
Tan, Eugene S.J., Siew Pang Chan, Chang Xu, et al.. (2019). Cornell product is an ECG marker of heart failure with preserved ejection fraction. Heart Asia. 11(1). e011108–e011108. 9 indexed citations
6.
Yeo, Daniel, et al.. (2019). A Rare Delayed Atypical Pseudoprogression in Nivolumab-Treated Non-Small-Cell Lung Cancer. SHILAP Revista de lepidopterología. 2019. 1–4. 3 indexed citations
7.
Gohar, Aisha, Jenny Chong, Oi Wah Liew, et al.. (2017). The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection Fraction. European Journal of Heart Failure. 19(12). 1638–1647. 64 indexed citations
8.
Bosch, Lena, Carolyn S.P. Lam, Lingli Gong, et al.. (2017). Right Ventricular Dysfunction in Left-Sided Heart Failure with Preserved Versus Reduced Ejection Fraction. European Journal of Heart Failure. 19(12). 1664–1671. 227 indexed citations
9.
Mentz, Robert J., Lothar Roessig, Barry Greenberg, et al.. (2016). Heart Failure Clinical Trials in East and Southeast Asia. JACC Heart Failure. 4(6). 419–427. 41 indexed citations
10.
Gijsberts, Crystel M., Lina Benson, Ulf Dahlström, et al.. (2016). Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure. Heart. 102(18). 1464–1471. 13 indexed citations
11.
Jaberzadeh, Shapour, Daniel Yeo, & Maryam Zoghi. (2015). The Effect of Altering Knee Position and Squat Depth on VMO : VL EMG Ratio During Squat Exercises. Physiotherapy Research International. 21(3). 164–173. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026